Molecular Imprints Grows Its IP Position with over 300 Patent Applications
MII continues to develop its Imprio(R) nano-lithography product line for numerous market opportunities. Intellectual property is a critical component of MII's business strategy. It also demonstrates the broad and deep technical capabilities of the Company.
“This milestone is a testament to the hard work and drive of our technical staff and reflects our desire to protect our investor's equity going forward.”
Dr. S.V. Sreenivasan, MII's CTO, states, "These patent applications are related to all aspects of Molecular Imprints' proprietary S-FIL technology. In addition, many also address other forms of imprint lithography, and nano and 3D patterning in general."
Dr. Norm Schumaker, MII's CEO, said, "This milestone is a testament to the hard work and drive of our technical staff and reflects our desire to protect our investor's equity going forward."
About Molecular Imprints Inc.
Molecular Imprints, Inc. (MII) is a global developer and manufacturer of nano-lithography systems for high resolution and for 3-dimensional pattern replication. The company has commercialized a proprietary imprint lithography technology (S-FIL), which is a room temperature, low pressure, non-contact imprint process that has demonstrated sub-20 nanometer resolution. Molecular Imprints provides enabling lithography systems and technology for manufacturing applications in the areas of: nano-devices, magnetic data storage applications, solid state lighting, micro optical components, compound semiconductors ad select silicon applications. For more information, visit: www.molecularimprints.com.